Table 3.
Correlation analysis of GAS5 expression and clinicopathologic features of TNBC patients.
| Clinical feature | Number of cases | GAS5 expression | P |
|---|---|---|---|
| Age (years) | 0.249 | ||
| < 60 | 56 | 0.30 ± 0.08 | |
| ≥ 60 | 42 | 0.35 ± 0.09 | |
| Types of tumor | 0.727 | ||
| Ductal carcinoma | 62 | 0.29 ± 0.18 | |
| Lobular carcinoma | 24 | 0.27 ± 0.16 | |
| Simple carcinoma | 12 | 0.25 ± 0.17 | |
| Size of tumor (cm) | < 0.001 | ||
| < 2 | 52 | 0.61 ± 0.17 | |
| ≥ 2 | 46 | 0.28 ± 0.18 | |
| Lymphatic metastasis | < 0.001 | ||
| Exist | 61 | 0.30 ± 0.14 | |
| Non-exist | 37 | 0.65 ± 0.10 | |
| Clinical stage | < 0.001 | ||
| Ⅰ/Ⅱ stage | 56 | 0.60 ± 0.11 | |
| Ⅲ/Ⅳ stage | 42 | 0.24 ± 0.13 |